579 results on '"Lane, J Athene"'
Search Results
102. Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT
103. The ProtecT randomised trial cost-effectiveness analysis comparing active monitoring, surgery, or radiotherapy for prostate cancer
104. Prostate-specific antigen testing and prostate biopsy: are self-reported lower urinary tract symptoms and health-related quality of life associated with the decision to undergo these investigations?
105. Associations of lower urinary tract symptoms with prostate-specific antigen levels, and screen-detected localized and advanced prostate cancer: a case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatment) study
106. Investigating the effects of lycopene and green tea on the metabolome of men at risk of prostate cancer:The ProDiet randomised controlled trial
107. What accompanies a postal questionnaire and why does it matter?
108. Quality control of uroflowmetry and urodynamic data from two large multicenter studies of male lower urinary tract symptoms
109. Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received
110. Phase II randomised control feasibility trial of a nutrition and physical activity intervention after radical prostatectomy for prostate cancer
111. Best emollients for eczema (BEE) – comparing four types of emollients in children with eczema: protocol for randomised trial and nested qualitative study
112. A third trial oversight committee: Functions, benefits and issues
113. Two-step Randomisation: Applying the Results of Small Feasibility Studies of Interventions to Large-scale Mendelian Randomisation Studies to Robustly Infer Causal Effects on Clinical Endpoints
114. Systematic Review and Meta-Analysis of the Associations Between Body Mass Index, Prostate Cancer, Advanced Prostate Cancer and Prostate Specific Antigen
115. Factors associated with trial recruitment, preferences, and treatments received were elucidated in a comprehensive cohort study
116. TReatIng Urinary symptoms in Men in Primary Healthcare using non-pharmacological and non-surgical interventions (TRIUMPH) compared with usual care: study protocol for a cluster randomised controlled trial
117. Challenges to and Facilitators of Recruitment to an Alzheimer’s Disease Clinical Trial: A Qualitative Interview Study
118. PD10-08 THULIUM LASER TRANSURETHRAL VAPORESECTION OF THE PROSTATE VERSUS TRANSURETHRAL RESECTION OF THE PROSTATE: RESULTS OF THE UNBLOCS RANDOMIZED CONTROLLED TRIAL
119. Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT Study
120. The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF-I, IGF-II, IGFBP-1, IGFBP-2 and IGFBP-3 in a pooled analysis of 16,024 men from 22 studies
121. Prostate Specific Antigen (PSA) testing of men in UK general practice::a 10-year longitudinal cohort study
122. Reducing attrition within clinical trials: The communication of retention and withdrawal within patient information leaflets
123. Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT Study
124. A Genetic Risk Score to Personalize Prostate Cancer Screening, Applied to Population Data.
125. ProDiet: A Phase II Randomized Placebo-controlled Trial of Green Tea Catechins and Lycopene in Men at Increased Risk of Prostate Cancer
126. A prospective cohort and extended comprehensive-cohort design provided insights about the generalizability of a pragmatic trial: the ProtecT prostate cancer trial
127. Contemporary accuracy of death certificates for coding prostate cancer as a cause of death: Is reliance on death certification good enough? A comparison with blinded review by an independent cause of death evaluation committee
128. Characteristics of men responding to an invitation to undergo testing for prostate cancer as part of a randomised trial
129. What are the roles and valued attributes of a Trial Steering Committee?:A ethnographic study of 8 clinical trials facing challenges
130. Systematic review evaluating randomized controlled trials of smoking and alcohol cessation interventions in people with head and neck cancer and oral dysplasia
131. A randomized controlled feasibility trial of green tea and lycopene interventions in men at elevated risk of prostate cancer (ProDiet)
132. Developing new age-specific prostate-specific antigen thresholds for testing for prostate cancer
133. ‘Recruitment, recruitment, recruitment’ – the need for more focus on retention: a qualitative study of five trials
134. A cohort examination to establish reporting of the remit and function of Trial Steering Committees in randomised controlled trials
135. ‘We all want to succeed, but we’ve also got to be realistic about what is happening’: an ethnographic study of relationships in trial oversight and their impact
136. Acceptability of dietary and physical activity lifestyle modification for men following radiotherapy or radical prostatectomy for localised prostate cancer: a qualitative investigation
137. Statistical analysis plan for the Urodynamics for Prostate Surgery Trial; Randomised Evaluation of Assessment Methods (UPSTREAM)
138. Barriers and facilitators to healthy lifestyle and acceptability of a dietary and physical activity intervention among African Caribbean prostate cancer survivors in the UK: a qualitative study
139. Post-diagnosis serum insulin-like growth factors in relation to dietary and lifestyle changes in the Prostate testing for cancer and Treatment (ProtecT) trial
140. A randomised controlled trial to determine the clinical and cost effectiveness of thulium laser transurethral vaporesection of the prostate (ThuVARP) versus transurethral resection of the prostate (TURP) in the National Health Service (NHS) – the UNBLOCS trial: a study protocol for a randomised controlled trial
141. Establishing nurse-led active surveillance for men with localised prostate cancer: development and formative evaluation of a model of care in the ProtecT trial
142. A third trial oversight committee: Functions, benefits and issues.
143. Prostate cancer survivors' preferences on the delivery of diet and lifestyle advice: a pilot best-worst discrete choice experiment.
144. Incorporating Known Genetic Variants Does Not Improve the Accuracy of PSA Testing to Identify High Risk Prostate Cancer on Biopsy
145. The feasibility of the Prostate cancer: Evidence of Exercise and Nutrition Trial (PrEvENT) dietary and physical activity modifications: a qualitative study
146. Mortality Among Men with Advanced Prostate Cancer Excluded from the ProtecT Trial
147. The provision of dietary and physical activity advice for men diagnosed with prostate cancer: a qualitative study of the experiences and views of health care professionals, patients and partners
148. Characteristics of men responding to an invitation to undergo testing for prostate cancer as part of a randomised trial.
149. What are the roles and valued attributes of a Trial Steering Committee? ethnographic study of eight clinical trials facing challenges
150. Investigating the prostate specific antigen, body mass index and age relationship: is an age–BMI-adjusted PSA model clinically useful?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.